SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GESSI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.274
AS - Asia 15.931
EU - Europa 10.594
SA - Sud America 2.442
Continente sconosciuto - Info sul continente non disponibili 431
AF - Africa 321
OC - Oceania 26
Totale 58.019
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.631
SG - Singapore 5.666
CN - Cina 4.148
IT - Italia 3.090
BR - Brasile 1.895
DE - Germania 1.848
VN - Vietnam 1.770
UA - Ucraina 1.483
HK - Hong Kong 1.307
TR - Turchia 1.104
GB - Regno Unito 856
FI - Finlandia 695
FR - Francia 637
SE - Svezia 502
RU - Federazione Russa 477
BD - Bangladesh 450
JP - Giappone 392
CA - Canada 323
IN - India 316
PL - Polonia 312
MX - Messico 221
NL - Olanda 207
AR - Argentina 201
ID - Indonesia 136
IQ - Iraq 126
ZA - Sudafrica 117
ES - Italia 110
EC - Ecuador 82
CO - Colombia 76
PK - Pakistan 67
LT - Lituania 66
BE - Belgio 62
VE - Venezuela 57
UZ - Uzbekistan 54
CL - Cile 47
MA - Marocco 47
MY - Malesia 45
AE - Emirati Arabi Uniti 44
SA - Arabia Saudita 44
TN - Tunisia 38
AT - Austria 37
CZ - Repubblica Ceca 37
PH - Filippine 36
PY - Paraguay 32
KE - Kenya 29
NP - Nepal 25
JO - Giordania 22
AU - Australia 21
DZ - Algeria 19
EG - Egitto 19
IE - Irlanda 18
AL - Albania 17
IL - Israele 17
UY - Uruguay 17
IR - Iran 15
JM - Giamaica 15
PE - Perù 15
RO - Romania 14
AZ - Azerbaigian 13
BO - Bolivia 13
PT - Portogallo 13
TW - Taiwan 13
CH - Svizzera 12
CR - Costa Rica 12
KR - Corea 12
LB - Libano 12
BG - Bulgaria 11
OM - Oman 11
TH - Thailandia 11
HN - Honduras 10
PS - Palestinian Territory 10
TT - Trinidad e Tobago 10
GR - Grecia 9
HR - Croazia 9
RS - Serbia 9
SV - El Salvador 9
HU - Ungheria 8
PA - Panama 8
BA - Bosnia-Erzegovina 7
ET - Etiopia 7
EU - Europa 7
GT - Guatemala 7
KG - Kirghizistan 7
KZ - Kazakistan 7
LV - Lettonia 7
NI - Nicaragua 7
SN - Senegal 7
BY - Bielorussia 6
DO - Repubblica Dominicana 6
MN - Mongolia 6
SK - Slovacchia (Repubblica Slovacca) 6
SY - Repubblica araba siriana 6
AO - Angola 5
BH - Bahrain 5
CI - Costa d'Avorio 5
GE - Georgia 5
GY - Guiana 5
MD - Moldavia 5
MK - Macedonia 5
NG - Nigeria 5
Totale 57.502
Salva come PNG Salva come JPEG
Città #
Singapore 3.681
Ashburn 2.926
Woodbridge 2.408
Fairfield 2.037
San Jose 1.903
Jacksonville 1.591
Chandler 1.581
Houston 1.504
Hong Kong 1.284
Beijing 1.236
Santa Clara 1.212
Ann Arbor 1.187
Wilmington 865
Seattle 839
Cambridge 671
Ho Chi Minh City 593
Izmir 518
Los Angeles 514
Dallas 500
Nanjing 490
Hanoi 428
Milan 379
Tokyo 373
Princeton 361
New York 357
Ferrara 332
Council Bluffs 314
Munich 305
Boardman 299
Lauterbourg 295
Warsaw 260
Helsinki 255
Shanghai 196
São Paulo 185
San Diego 173
Nanchang 165
Shenyang 152
Dearborn 149
Orem 134
London 130
Mexico City 127
Tianjin 126
Turku 126
Rome 125
Buffalo 122
Addison 111
Hefei 109
Bremen 104
Falkenstein 104
Changsha 102
Montreal 100
Hebei 98
Chicago 96
Frankfurt am Main 93
Toronto 93
Da Nang 90
Brooklyn 85
Bologna 80
Jakarta 80
Haiphong 75
The Dalles 74
Jiaxing 73
Chennai 70
Atlanta 67
Florence 66
Jinan 64
Denver 63
Johannesburg 62
Manchester 61
Rio de Janeiro 61
Stockholm 61
Moscow 60
San Mateo 60
Phoenix 58
San Francisco 58
Brussels 57
Norwalk 56
Mountain View 51
Zhengzhou 51
Baghdad 50
Boston 50
Tashkent 50
Amsterdam 49
Kunming 49
Poplar 49
Guangzhou 47
Mumbai 44
Falls Church 43
Naples 43
Belo Horizonte 41
Düsseldorf 38
Orange 36
Auburn Hills 35
Biên Hòa 35
Hải Dương 35
Philadelphia 35
Redwood City 35
Verona 34
Ningbo 33
Washington 32
Totale 36.864
Salva come PNG Salva come JPEG
Nome #
Farmacologia cellulare e molecolare, sistemi di trasmissione e autacoidi. Trasmissione purinergica 1.431
PRIN 2007 Coordinatore Nazionale del progetto Dott. Stefania Gessi- Il recettore A3 dell’adenosina: un potenziale bersaglio per la diagnosi, prognosi e terapia del cancro colorettale 671
Pharmacology of Adenosine Receptors: The State of the Art 412
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 333
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 324
A glance at adenosine receptors: Novel target for antitumor therapy 312
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 306
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 303
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 290
The A3 adenosine receptor: history and perspectives 289
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 286
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 270
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 268
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 263
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 261
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 259
Adenosine receptors and human melanoma 258
Antioxidant and antiinflammatory effects of epilobium parviflorum, melilotus officinalis and cardiospermum halicacabum plant extracts in macrophage and microglial cells 258
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 254
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 252
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 251
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 247
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats 247
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 246
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 244
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 244
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells 238
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 237
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 237
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 236
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 230
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 229
Adenosine receptors and cancer 227
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 226
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 226
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 226
Adenosine receptor targeting in health and disease 224
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 221
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 220
4-(4-Fluorobenzoyl)-1-[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]piperidine and its derivatives: Synthesis and affinity at 5-HT(2A), 5-HT(2B) and 5- HT(2C) serotonin receptors 220
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 220
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 219
van't Hoff Based Thermodynamics 219
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 218
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 218
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 217
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 217
Targeting A3 and A2A adenosine receptors in the fight against cancer 217
Pathological overproduction: the bad side of adenosine 216
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 215
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 214
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 214
Agonists and antagonists: Molecular mechanisms and therapeutic applications 214
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 213
3H SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes 212
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 210
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 208
THERMODYNAMICS OF A2B ADENOSINE RECEPTOR BINDING DISCRIMINATES AGONISTIC FROM ANTAGONISTIC BEHAVIOUR 208
Adenosine receptors in health and disease 208
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 208
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 207
Farmacologia cellulare e molecolare, sistemi di trasmissione. Trasmissione purinergica. 207
Adenosine and lymphocyte regulation 206
Binding thermodynamics at A1 and A2A adenosine receptors 205
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 205
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 205
Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A3 adenosine receptors. 204
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. 202
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. 202
[3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 202
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 202
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 201
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A(3) adenosine receptors in human renal cells: Implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells. 201
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 200
Binding thermodynamics of 5-HT(1A) receptor ligands 200
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 199
Pulsed electromagnetic field and relief of hypoxia-induced neuronal cell death: The signaling pathway 198
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour 197
A(2A) adenosine receptors in human peripheral blood cells 197
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2receptor antagonists/inverse agonists 197
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 197
Changes in hippocampal and cortical B1 bradykinin receptor biological activity in two experimental models of epilepsy 197
Pharmacological characterization of adenosine receptors in bovine chondrocytes. 196
Adenosine modulates HIF-1, VEGF, IL-8 and foam cells formation in a human model of hypoxic foam cells 196
[3H]MRE3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 196
Adenosine receptors and cancer 196
A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells: a pharmacological and biochemical study. 195
A convenient synthesis by microwave heating and pharmacological evaluation of novel benzoyltriazole and saccharine derivatives as 5-HT(1A) receptor ligands 195
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 194
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 193
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 193
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 193
Differential expression of A3 adenosine receptors in colorectal cancer and related mucosa: a mirror in blood cells. 192
Adenosine in a human model of Hypoxic foam cells 191
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 191
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells 188
Adenosine modulates HIF-1α, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells 187
[3H] CGS 21680 binding to purified adenosine A2A receptors in human platelets 187
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 186
New potent and selective human adenosine A3 receptor antagonists. 186
Totale 24.147
Salva come PNG Salva come JPEG
Categoria #
all - tutte 243.528
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 12.336
Totale 255.864
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.182 68 328 207 157 141 135 118 174 113 266 459 1.016
2022/20233.721 360 289 119 500 617 497 183 308 461 43 202 142
2023/20242.024 181 253 100 48 230 217 101 133 51 96 100 514
2024/20257.724 188 220 612 424 973 666 314 473 1.036 864 1.071 883
2025/202621.563 2.183 823 1.824 2.718 3.007 1.456 2.498 1.120 2.100 2.428 858 548
2026/2027583 583 0 0 0 0 0 0 0 0 0 0 0
Totale 58.019